Fennec Pharmaceuticals Inc.
NASDAQ:FENC
5.72 (USD) • At close January 15, 2025
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Omzet
| 21.252 | 1.535 | 0 | 0.17 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Kosten van de omzet
| 1.259 | 0.086 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.055 | 0 |
| Brutowinst
| 19.993 | 1.449 | 0 | 0.17 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.055 | 0 |
| Brutowinstmarge
| 0.941 | 0.944 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 83,597 | 1 |
| Onderzoek- en ontwikkelingskosten
| 0.056 | 3.531 | 4.981 | 5.105 | 5.607 | 5.008 | 1.936 | 0.472 | 0.256 | 0.357 | 0.597 | 2.075 | 1.494 | 0.708 | 2.113 | 10.366 | 10.912 | 14.003 | 12.441 | 3.588 | 3.546 | 3.134 | 1.91 | 0.939 |
| Algemene en administratieve kosten
| 20.585 | 17.722 | 12.242 | 12.95 | 7.402 | 5.401 | 5.015 | 2.399 | 1.634 | 2.52 | 1.334 | 1.545 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Verkoop- en marketingkosten
| 12.123 | 2.785 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Verkoop-, algemene en administratieve kosten
| 32.708 | 20.507 | 12.242 | 12.95 | 7.402 | 5.401 | 5.015 | 2.399 | 1.634 | 2.52 | 1.334 | 1.545 | 1.944 | 3.896 | 1.214 | 3.52 | 3.278 | 2.883 | 3.182 | 3.494 | 1.781 | 0.907 | 0.739 | 0.614 |
| Overige kosten
| 0 | 0 | 0 | -0.009 | -0.017 | 0.006 | -0.008 | -0.014 | 0 | 0 | -0.003 | -0.005 | 0 | 0 | 0 | 0 | 0 | 2.177 | 2.723 | 2.34 | 1.418 | 0 | 0.055 | 0.052 |
| Bedrijfskosten
| 32.764 | 24.038 | 17.223 | 18.055 | 13.009 | 10.409 | 6.951 | 2.871 | 1.89 | 2.877 | 1.931 | 3.62 | 3.438 | 4.604 | 2.83 | 13.886 | 14.19 | 19.063 | 18.346 | 9.422 | 6.745 | 4.041 | 2.704 | 1.606 |
| Bedrijfsresultaat
| -12.771 | -22.589 | -17.223 | -17.885 | -13.009 | -10.409 | -6.951 | -2.871 | -1.89 | -2.877 | -1.931 | -3.62 | -3.438 | -4.604 | -3.216 | -13.886 | -14.19 | -19.063 | -18.346 | -9.422 | -6.745 | -4.041 | -2.649 | -1.606 |
| Bedrijfsresultaat ratio
| -0.601 | -14.716 | 0 | -105.206 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -4,009,001.123 | -2,376,299.432 |
| Totaal overige inkomsten en kosten netto
| -3.274 | -1.125 | -0.123 | -0.224 | 0.234 | 0.521 | -0.095 | 0.082 | 1.283 | 0.701 | 3.776 | -1.543 | 8.123 | -3.505 | 0.204 | 0 | 0.906 | -1.535 | -3.992 | -0.227 | 0.079 | 0.321 | 0.194 | 0.008 |
| Inkomen voor belasting
| -16.045 | -23.714 | -17.346 | -18.109 | -12.775 | -9.888 | -7.046 | -2.789 | -0.659 | -2.176 | 1.845 | -5.163 | 4.685 | -7.823 | -3.012 | -13.6 | -13.357 | -20.638 | -21.535 | -9.593 | -6.665 | -3.72 | -2.455 | -1.597 |
| Inkomen voor belasting ratio
| -0.755 | -15.449 | 0 | -106.524 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3,715,126.04 | -2,364,003.67 |
| Belastingkosten
| 0 | 1.125 | 0.11 | -0.187 | -0.315 | -0.348 | -0.047 | -0.008 | -0.003 | -0.002 | -0.002 | -0.025 | -0.043 | 7.823 | 3.012 | 13.6 | 13.357 | -1.535 | -2.29 | -0.855 | -0.518 | 3.72 | 2.455 | 1.597 |
| Nettowinst
| -16.045 | -24.839 | -17.456 | -17.922 | -12.46 | -9.888 | -7.046 | -2.789 | -0.659 | -2.176 | 1.845 | -5.163 | 4.685 | -7.823 | -3.012 | -13.6 | -13.357 | -19.103 | -19.245 | -8.737 | -6.147 | -3.72 | -2.455 | -1.597 |
| Nettowinstmarge
| -0.755 | -16.182 | 0 | -105.424 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3,715,126.04 | -2,364,003.67 |
| WPA (Winst Per Aandeel)
| -0.6 | -0.95 | -0.67 | -0.76 | -0.63 | -0.52 | -0.47 | -0.22 | -0.061 | -0.22 | 0.19 | -0.63 | 0.59 | -1.11 | -0.98 | -4.43 | -4.78 | -16.72 | -20.45 | -15.04 | -19.85 | -19.32 | -20.12 | -2.98 |
| Verwaterde WPA
| -0.6 | -0.95 | -0.67 | -0.76 | -0.63 | -0.52 | -0.47 | -0.22 | -0.061 | -0.22 | 0.17 | -0.62 | 0.58 | -1.11 | -0.98 | -4.43 | -4.78 | -16.72 | -20.45 | -15.04 | -19.85 | -19.32 | -4.04 | -2.98 |
| EBITDA
| -12.364 | -22.587 | -0.123 | -17.885 | 0.234 | 0.521 | -0.095 | 0.082 | -1.89 | -2.877 | 1.789 | -5.183 | 4.552 | -4.604 | -2.601 | -13.886 | -14.19 | -17.906 | -19.27 | -12.561 | -5.218 | -4.239 | -2.788 | -2.594 |
| EBITDA ratio
| -0.582 | -14.686 | 0 | -105.794 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -4,219,281.181 | -2,311,624.326 |